Skip to main content
Premium Trial:

Request an Annual Quote

Cohesive Technologies Wins Patent Suit Against Waters

NEW YORK, Nov. 29 – A Boston jury found that Waters Corporation infringed upon a patent for high throughput liquid chromatography held by Cohesive Technologies, the companies announced Thursday.

The patent, number 5,772,874, is used in Cohesive’s technology in its TurboFlow high throughput liquid chromatography product, according to the company.

“With this lawsuit behind us, we're ready to fast-forward our marketing efforts and pursue strategic relationships with a number of outstanding partners who have been waiting for this suit to be resolved,” Peter Glick, CEO of Franklin, Mass.-based Cohesive, said in a statement. 

Waters said in a statement that the product that used what Cohesive alleged was a patent violation had been removed from its US product line prior to the trial, and that the product “was replaced by a product with better performance.”

Milford, Mass.-based Waters said it would be appealing the court decision.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.